<DOC>
	<DOC>NCT00112515</DOC>
	<brief_summary>RATIONALE: Modafinil may help relieve fatigue and improve quality of life in patients with cancer. PURPOSE: This clinical trial is studying how well modafinil works in treating fatigue in patients with cancer.</brief_summary>
	<brief_title>Modafinil in Treating Fatigue in Patients With Cancer</brief_title>
	<detailed_description>OBJECTIVES: Primary - Determine the safety of modafinil in cancer patients. - Determine the efficacy of this drug, in terms of improving fatigue, in these patients. Secondary - Determine the efficacy of this drug, in terms of improving mood, cognitive ability, functional status, and quality of life, in these patients. OUTLINE: This is a nonrandomized, pilot study. Patients receive oral modafinil once daily for 4 weeks in the absence of disease progression or unacceptable toxicity. Patients may receive additional modafinil at the discretion of the physician. Fatigue, mood, cognition, functional status, and quality of life are assessed at baseline and in weeks 2 and 4. After completion of study treatment, patients are followed at 30 days. PROJECTED ACCRUAL: A total of 26 patients will be accrued for this study within 9 months.</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS: Diagnosis of cancer Brief Fatigue Inventory score â‰¥ 4 PATIENT CHARACTERISTICS: Age 18 and over Performance status ECOG 13 Life expectancy At least 2 months Hematopoietic Not specified Hepatic Not specified Renal Not specified Cardiovascular No history of left ventricular hypertrophy No history of ischemic ECG changes No history of chest pain No history of arrhythmia No history of other clinically significant manifestations of mitral valve prolapse in association with CNS stimulant use Other Not pregnant or nursing Negative pregnancy test Thyroid stimulating hormone normal No known hypersensitivity to modafinil No history of psychotic disorder and/or active psychosis No history of any chronic medical or psychiatric condition or laboratory abnormality that would preclude study participation or compliance PRIOR CONCURRENT THERAPY: Biologic therapy Concurrent thalidomide allowed Chemotherapy Not specified Endocrine therapy Not specified Radiotherapy Not specified Surgery Not specified Other Concurrent narcotics, phenothiazines, or benzodiazepines allowed No other concurrent investigational therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>depression</keyword>
	<keyword>cognitive/functional effects</keyword>
	<keyword>fatigue</keyword>
	<keyword>unspecified adult solid tumor, protocol specific</keyword>
</DOC>